NGEN NASDAQ
NervGen Pharma Corp. Common stock
1W: -4.6%
1M: -11.0%
3M: -14.4%
YTD: -39.5%
$3.56
-0.08 (-2.20%)
Pre-Market: $3.69 (+0.13, +3.65%)
Weekly Expected Move ±6.1%
$3
$3
$4
$4
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Last Earnings
2026-05-18
EPS
$-0.07
▲ Beat +11.6%
Revenue
$4K
Est (actual pending)
Next Earnings
2026-08-21
EPS Estimate
$-0.08
Range: $-0.08 - $-0.07
Revenue Estimate
$4K
3 analysts
Estimate vs Actual
Earnings Surprise History
1/2
EPS Beats
0/2
Revenue Beats
50%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-05-19 | quarter | 2026-06-30 | $-0.08 | $-0.08 | — | $4,500 | $4,500 |
| 2026-05-19 | quarter | 2027-03-31 | $-0.10 | $-0.10 | — | $— | $— |
| 2026-05-19 | quarter | 2027-06-30 | $-0.09 | $-0.09 | — | $— | $— |
| 2026-05-19 | quarter | 2027-12-31 | $-0.10 | $-0.10 | — | $— | $— |
| 2026-05-19 | quarter | 2026-12-31 | $-0.09 | $-0.09 | — | $— | $— |
| 2026-05-19 | annual | 2027-12-31 | $-0.36 | $-0.36 | — | $— | $— |
| 2026-05-19 | quarter | 2026-09-30 | $-0.08 | $-0.08 | — | $— | $— |
| 2026-05-19 | annual | 2026-12-31 | $-0.32 | $-0.31 | ▲ 0.01 | $— | $— |
| 2026-05-19 | quarter | 2027-09-30 | $-0.10 | $-0.10 | — | $— | $— |
| 2026-04-30 | quarter | 2026-03-31 | $-0.07 | $-0.07 | — | $4,500 | $4,500 |
| 2026-04-30 | quarter | 2026-12-31 | $-0.09 | $-0.09 | — | $— | $— |
| 2026-04-30 | quarter | 2026-09-30 | $-0.08 | $-0.08 | — | $— | $— |
| 2026-04-30 | quarter | 2027-12-31 | $-0.09 | $-0.10 | ▼ 0.01 | $— | $— |
| 2026-04-30 | quarter | 2027-09-30 | $-0.09 | $-0.10 | ▼ 0.01 | $— | $— |
| 2026-04-30 | annual | 2027-12-31 | $-0.33 | $-0.36 | ▼ 0.03 | $— | $— |
Earnings Call Transcripts
No transcripts available.